Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2021 Mar 1.

Published in final edited form as: Eur J Clin Microbiol Infect Dis. 2019 Nov 22;39(3):455–463. doi: 10.1007/s10096-019-03744-3

Fig. 3. — A. All patients. B. Excludes patients that received thymoglobulin in the first year after kidney transplantation. Cohort 0 (blue): 40-60 years of age. Cohort 1 (red): aged ≥ 65 years. Hz: hazard ratio. While the older group had a higher risk of CMV reactivation, after the initial episode the relative hazards of were approximately equal between the age groups (at period 2).

Fig. 3. — A. All patients. B. Excludes patients that received thymoglobulin in the first year after kidney transplantation. Cohort 0 (blue): 40-60 years of age. Cohort 1 (red): aged ≥ 65 years. Hz: hazard ratio. While the older group had a higher risk of CMV reactivation, after the initial episode the relative hazards of were approximately equal between the age groups (at period 2).